Researchers were awarded approximately $3 million from the National Institutes of Health to continue studying how our bodies respond to seasonal and pandemic flu viruses and vaccines.
Scientists are scrambling to gather data for the FDA to support the need for a blood test to diagnose brain injury in the United States. The University of Rochester Medical Center just added significant evidence by reporting in the Journal of Neurotrauma that it might be clinically useful to measure two brain biomarkers instead of one.
First, the good news: The survival rate for testicular cancer is 95 percent at 10 years, due to the invention of cisplatin-based chemotherapy in the 1970s. Despite this success, however, survivors have an increasing risk of second malignancies -- and the risk remains elevated for 35 years.
A new vaccine for norovirus – the microbe behind most cases of what people commonly call stomach flu – protected patients against severe vomiting and diarrhea. URMC was one of five study sites that enrolled patients and tested the experimental vaccine.
Those fascinating creatures are in the news again. In a study published in June researchers found a key to their cancer resistance. This week, University of Rochester biologists showed that the rodent’s longevity – they live a healthy 30 years, which is very long in rat years – is due to better-constructed proteins.
A study in the Annals of Surgery found that smoking boosts the risk of complications like infection and pneumonia after some of the most common colorectal procedures. Author Fergal Fleming, M.D., breaks down the risks in this video.
The goal of this blog is to bring more medical research stories to light and provide our readers with timely and engaging coverage of scientific and medical developments here in Rochester and beyond.
April 2014 (6)
March 2014 (8)
February 2014 (11)
January 2014 (6)
December 2013 (10)
November 2013 (5)
October 2013 (8)
September 2013 (7)
August 2013 (12)
July 2013 (12)
June 2013 (14)
May 2013 (2)